BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of investors of United Therapeutics Corporation ("United Therapeutics" or the "Company") (NASDAQGS: UTHR), concerning whether the Company misled investors regarding its compliance with applicable healthcare laws.
On July 27, 2017, United Therapeutics disclosed that it recorded a $210 million charge relating to a potential settlement with the United States Department of Justice. The settlement arises out of allegations that the Company violated Federal Anti-Kickback Statute and the Federal False Claims Act resulting from the Company's contributions to certain charities to assist United Therapeutics patients to meet certain minimum requirements to qualify for government assistance.
If you purchased United Therapeutics securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to email@example.com, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.